Press Releases

Weissman and Johns Hopkins’ Bert Vogelstein will share the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for discoveries in stem cell and cancer biology.

Stanford researchers blocked a molecule to help restore neurons in rats in which the flow of fresh blood to the brain was reduced. The approach could lead to new treatments for people who have suffered a stroke or cardiac arrest.

The bacteria in and on our bodies make thousands of tiny, previously unidentified proteins that could shed light on human health and advance drug development, Stanford researchers have found.

Applying a gel to internal tissues of animals after cardiac surgery significantly limits the formation of adhesions, a problematic form of scar tissue, Stanford researchers have found.

Stanford researchers have identified immune cells that help reduce the severity of a disease in mice akin to multiple sclerosis. These cells could one day be useful therapeutic targets in treating autoimmune diseases.

Tapping the interests and motivations of children with autism can help them understand the value of speaking and build their social skills, a new Stanford study found.

A large multicenter clinical trial led by Stanford physician Tait Shanafelt, MD, indicates that people with chronic lymphocytic leukemia may forgo chemotherapy in favor of new, targeted treatments.

Cancer cells are known to protect themselves using proteins that tell immune cells not to attack them. Stanford researchers have discovered a new “don’t eat me” signal, and blocking it may make cancer cells vulnerable to attack by the immune system.

Stanford scientists and their collaborators have discovered the protective role played by identity-morphing cells — and the gene behind them — in atherosclerosis, according to a new study.

Stanford researchers identified a gene crucial to the formation of toxic proteins in amyotrophic lateral sclerosis and showed how it could inform potential therapies for the disease.